BU-NOT-SET

CONTACT US
Dosage form development trends and technologies
  • Drug product
Eyes
Insight
Vaccine Development and Manufacturing
  • Drug product
  • Manufacturing
Eyes
Insight
Identifying impurities using advanced analytics
  • Analytical chemistry
Eyes
Insight
Recipharm on the impact of COVID-19 on API supply
  • Industry trends
Eyes
Insight
The role of excipient selection in the development of orally disintegrating tablets
  • Drug product
Eyes
Insight
Solving analytical method challenges to advance animal antibiotic
  • Analytical chemistry
Hand vial stand
Case study
The outlook for a year of change
  • Industry trends
Eyes
Insight
Can oral solid dose keep its place as the leading dosage form?
  • Drug product
Eyes
Insight
Relocating API supply to avoid over-reliance
  • Drug substance
Eyes
Insight
Insight
  • Drug product
  • Industry trends
2023: fill and finish demand expected to continue as the industry faces new challenges
Insight
  • Drug product
  • Industry trends
What does 2023 hold for oral solid dosage forms?
Insight
  • Sustainability
Is it time to introduce science based targets for climate change?
Insight
  • Drug product
  • Industry trends
Addressing the key pitfalls hindering technology transfer success
Case study
  • Analytical chemistry
  • Drug product
Overcoming tablet dissolution challenges with formulation expertise
Insight
  • Industry trends
  • Manufacturing
Today’s potent oral dose forms require flexible manufacturing environments
Insight
  • Analytical chemistry
  • Drug product
Benefits of reformulation strategies
Case study
  • Drug product
  • Manufacturing
Supporting first lyophilised mRNA vaccine to pivotal trial
Fact sheet
  • Drug product
  • Manufacturing
LAB+ blow-fill-seal system